SynthesisMedicine2025
Functional outcomes and complications following salvage radical prostatectomy for post radiotherapy recurrent prostate cancer: A meta-analysis.
Synthesis in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Could the preoperative urethral curve be used to predict immediate urinary continence following Retzius-sparing robot-assisted radical prostatectomy? A retrospective multi-center study.International braz j urol : official journal of the Brazilian Society of UrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNumerous patients with radio-recurrent prostate cancer are treated with salvage open radical prostatectomy (RP) or robot-assisted RP. It's important to understand the side effects of these treatments. This study aimed to explore the rates and types of treatment-related adverse events.
methodsA thorough review of PubMed and EMBASE databases up to September 2024 was conducted, focusing on severe complications and functional outcomes at 1-year after salvage surgery. Severe complications were assessed using the Clavien-Dindo scale. Functional outcomes included urinary incontinence and erectile dysfunction (ED).
resultsA total of 34 studies were included, comprising 28 investigations on serious complications and 20 studies focused on functional outcomes. The overall incidence of serious complications was 14.56% (95% confidence interval [CI]: 13.44-15.74%), with the highest rates observed for urethral stricture (5.90%, 95% CI: 4.23-7.98%). One year post-salvage surgery, the incidence of any-grade urinary incontinence (≥1 pad/d), moderate to severe incontinence (≥2 pads/d), and severe incontinence (≥3 pads/d) was 49.57%, 24.62%, and 17.75%, respectively. Additionally, the incidence of ED following salvage RP at 1-year was 73.21%. There were no significant differences in the incidence of serious complications and ED between open and robotic surgery. However, the incidence of moderate to severe incontinence was lower in the robotic group (open vs robotic (43.36% vs 31.39%), odds ratio (OR; 95% CI) = 1.38 (1.14-1.68), P = .001). Patients with longer operative time had significantly higher rates of severe complications (≥150 minutes vs <150 minutes (16.85% vs 3.55%), OR 4.75 (95% CI: 2.92-7.71), P < .001) and moderate to severe urinary incontinence (≥150 minutes vs <150 minutes (40.31% vs 26.99%), OR 1.49 (95% CI: 1.17-1.90), P < .001).
conclusionFor radio-recurrent prostate cancer, salvage surgery should be performed with caution and only under strict indications due to the relatively high incidence of adverse events. Robotic surgery and shorter operative times are associated with a lower incidence of moderate to severe urinary incontinence, while longer operative times are linked to an increased risk of severe complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.